| P2093 | author name string | Tao Li | |
| | Wei Li | |
| | Zhuo Li | |
| | Ying Liu | |
| | Xiaopan Wu | |
| | Xilin Zhu | |
| | Xiaoshuang Yang | |
| | Jiaru Song | |
| P2860 | cites work | Current treatment guidelines of chronic hepatitis B: The role of nucleos(t)ide analogues and peginterferon | Q40107736 |
| | Interferon signal transduction of biphenyl dimethyl dicarboxylate/amantadine and anti-HBV activity in HepG2 2.2.15. | Q40271140 |
| | Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection | Q40696672 |
| | Antiviral activity of interferon-alpha against hepatitis B virus can be studied in non-hepatic cells and Is independent of MxA. | Q40758366 |
| | Genetic variation in STAT4 predicts response to interferon-α therapy for hepatitis B e antigen-positive chronic hepatitis B. | Q40857335 |
| | Transcriptional repression of the human p53 gene by hepatitis B viral X protein | Q40902803 |
| | RNA editing and hypermutation by adenosine deamination | Q41491657 |
| | Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development. | Q41901229 |
| | RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages | Q42683446 |
| | Regulation of MAVS activation through post-translational modifications | Q47565169 |
| | Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation | Q48370319 |
| | Role of microRNAs in the main molecular pathways of hepatocellular carcinoma. | Q55506760 |
| | TRADD Protein Is an Essential Component of the RIG-like Helicase Antiviral Pathway | Q57018246 |
| | The 3'UTR of human MAVS mRNA contains multiple regulatory elements for the control of protein expression and subcellular localization | Q58543860 |
| | Extensive editing of cellular and viral double-stranded RNA structures accounts for innate immunity suppression and the proviral activity of ADAR1p150 | Q59349577 |
| | Polymorphisms in ADAR1 gene affect response to interferon alpha based therapy for chronic hepatitis B in Han Chinese | Q83746882 |
| | Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss | Q90596734 |
| | Apoptotic Caspases Suppress Type I Interferon Production via the Cleavage of cGAS, MAVS, and IRF3 | Q92410384 |
| | An internal deletion of ADAR rescued by MAVS deficiency leads to a minute phenotype | Q92761429 |
| | Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus | Q21128797 |
| | Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase | Q24311306 |
| | MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response | Q24316320 |
| | IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction | Q24318426 |
| | STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling | Q24336398 |
| | AU-rich elements and associated factors: are there unifying principles? | Q24535929 |
| | Antiviral actions of interferons | Q24550676 |
| | The microRNA.org resource: targets and expression | Q24650094 |
| | Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3 | Q27861127 |
| | STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity | Q28509328 |
| | Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response | Q29617083 |
| | Hepatitis B virus infection--natural history and clinical consequences | Q29617961 |
| | Alu and b1 repeats have been selectively retained in the upstream and intronic regions of genes of specific functional classes | Q33519498 |
| | An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1). | Q33714407 |
| | Adenosine deaminases acting on RNA, RNA editing, and interferon action. | Q34553883 |
| | Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1 | Q35033687 |
| | Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis | Q35628610 |
| | The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. | Q35973393 |
| | Mechanisms of MAVS regulation at the mitochondrial membrane | Q36035399 |
| | Essential role of IPS-1 in innate immune responses against RNA viruses | Q36228730 |
| | Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide | Q36305699 |
| | Benefits and risks of interferon therapy for hepatitis B. | Q37462578 |
| | RNA editing by mammalian ADARs | Q37839347 |
| | A functional polymorphism in ADAR1 gene affects HBsAg seroclearance both spontaneously and interferon induced | Q39042138 |
| | Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways | Q39078459 |
| | ADAR1 is required for differentiation and neural induction by regulating microRNA processing in a catalytically independent manner | Q39313946 |
| | The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein | Q39691872 |
| | C1r and C1s from Nile tilapia (Oreochromis niloticus): Molecular characterization, transcriptional profiling upon bacterial and IFN-γ inductions and potential role in response to bacterial infection | Q40061866 |
| | Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections? | Q40097257 |
| P577 | publication date | 2020-12-03 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | ADAR1 stimulation by IFN-α downregulates the expression of MAVS via RNA editing to regulate the anti-HBV response | |